QNRX Stock: Quoin Pharmaceuticals, Ltd. Stock Price, Analysis & Insights
Get live qnrx stock price $12.09, comprehensive Quoin Pharmaceuticals, Ltd. stock analysis, charts, news, and expert forecast. Real-time qnrx stock data and investment insights.
Loading chart...
Company Overview
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
Company Information
- CEO
- Michael Myers
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 3
Contact Information
- Website
- https://quoinpharma.com
- Address
- 42127 Pleasant Forest Court
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.87)
Business Model & Strategy
Quoin Pharmaceuticals, Ltd. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Michael Myers, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Quoin Pharmaceuticals, Ltd. competes in the Biotechnology within the broader Healthcare. With 7.1 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Quoin Pharmaceuticals, Ltd. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Quoin Pharmaceuticals, Ltd. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Quoin Pharmaceuticals, Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Quoin Pharmaceuticals, Ltd.
- ⚠Investors should consider how Quoin Pharmaceuticals, Ltd. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
7.11M
P/E Ratio
-0.41
Beta
1.87
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 7.11M market capitalization
- Trading Volume: 535.57K shares traded today
- Price Range: 52-week range of $5.01 - $41.80
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd. (QNRX) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 7.11M, the company represents a significant player in its market. The stock is currently trading at $12.09 with a negativedaily change of 36.07%.
The company's 3 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.41, beta of 1.87, and 52-week price range from $5.01 to $41.80when evaluating investment opportunities.
Why Invest in Quoin Pharmaceuticals, Ltd.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Michael Myers
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.